Regeneron Pharmaceuticals
REGN
#275
Rank
โ‚ฌ68.54 B
Marketcap
646,70ย โ‚ฌ
Share price
1.32%
Change (1 day)
-5.93%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: โ‚ฌ68.54 Billion

As of December 2025 Regeneron Pharmaceuticals has a market cap of โ‚ฌ68.54 Billion. This makes Regeneron Pharmaceuticals the world's 275th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ68.54 B-8.89%
2024โ‚ฌ75.23 B-13.09%
2023โ‚ฌ86.55 B18.17%
2022โ‚ฌ73.24 B22.14%
2021โ‚ฌ59.96 B43.09%
2020โ‚ฌ41.91 B13.39%
2019โ‚ฌ36.96 B3.86%
2018โ‚ฌ35.58 B5.72%
2017โ‚ฌ33.66 B-8.54%
2016โ‚ฌ36.80 B-29.16%
2015โ‚ฌ51.95 B50.38%
2014โ‚ฌ34.55 B73.91%
2013โ‚ฌ19.86 B57.9%
2012โ‚ฌ12.58 B218.43%
2011โ‚ฌ3.95 B79.03%
2010โ‚ฌ2.20 B61.24%
2009โ‚ฌ1.36 B30.86%
2008โ‚ฌ1.04 B-19.8%
2007โ‚ฌ1.30 B31.11%
2006โ‚ฌ0.99 B31.32%
2005โ‚ฌ0.75 B99.74%
2004โ‚ฌ0.37 B-41.58%
2003โ‚ฌ0.64 B-17.62%
2002โ‚ฌ0.78 B-43.79%
2001โ‚ฌ1.40 B1.78%
2000โ‚ฌ1.37 B245.94%
1999โ‚ฌ0.39 B106.54%
1998โ‚ฌ0.19 B-13.61%
1997โ‚ฌ0.22 B-36.05%
1996โ‚ฌ0.34 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Regeneron Pharmaceuticals was reported to be:

โ‚ฌ67.08 Billion
by Nasdaq info icon info icon
โ‚ฌ67.64 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚ฌ150.75 B 119.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ45.53 B-33.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ21.57 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ428.01 B 524.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ223.49 B 226.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ100.39 B 46.47%๐Ÿ‡ซ๐Ÿ‡ท France